Suppr超能文献

手术切除的神经鞘瘤术前中性粒细胞与淋巴细胞比值的预后意义

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas.

作者信息

Takahara Kento, Tamura Ryota, Kuranari Yuki, Karatsu Kosuke, Akiyama Takenori, Toda Masahiro

机构信息

Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.

Department of Neurosurgery, Kawasaki Municipal Hospital, Kawasaki-ku, Kanagawa, Japan.

出版信息

Front Oncol. 2023 Feb 10;13:1099384. doi: 10.3389/fonc.2023.1099384. eCollection 2023.

Abstract

OBJECTIVE

The goal of schwannoma resection is to control the tumor while preserving neurological function. Schwannomas have a variable postoperative growth pattern, therefore preoperative prediction of a schwannoma's growth pattern is favorable. This study aimed to examine the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR) and postoperative recurrence and retreatment in patients with schwannoma.

METHODS

We retrospectively examined 124 patients who underwent schwannoma resection in our institution. Associations between preoperative NLR, other patient and tumor characteristics, and tumor recurrence and retreatment were analyzed.

RESULTS

Median follow-up was 2569.5 days. Postoperative recurrence occurred in 37 patients. Recurrence that required retreatment occurred in 22. Treatment-free survival (TFS) was significantly shorter in patients with NLR ≥2.21 ( = 0.0010). Multivariate Cox proportional hazards regression showed that NLR and neurofibromatosis type 2 were independent predictors of retreatment ( = 0.0423 and 0.0043, respectively). TFS was significantly shorter in patients with NLR ≥2.21 in the following subgroups: sporadic schwannoma, primary schwannoma, schwannoma ≥30 mm in size, subtotal resection, vestibular schwannoma, and postoperative recurrence.

CONCLUSIONS

Preoperative NLR ≥2.21 before surgery was significantly associated with retreatment after schwannoma resection. NLR may be a novel predictor of retreatment and assist surgeons in preoperative surgical decision making.

摘要

目的

神经鞘瘤切除的目标是在保留神经功能的同时控制肿瘤。神经鞘瘤术后生长模式各异,因此术前预测神经鞘瘤的生长模式是有益的。本研究旨在探讨神经鞘瘤患者术前中性粒细胞与淋巴细胞比值(NLR)与术后复发及再次治疗之间的关系。

方法

我们回顾性研究了在我院接受神经鞘瘤切除术的124例患者。分析术前NLR、其他患者及肿瘤特征与肿瘤复发和再次治疗之间的关联。

结果

中位随访时间为2569.5天。37例患者出现术后复发。22例复发需要再次治疗。NLR≥2.21的患者无治疗生存期(TFS)显著缩短(P = 0.0010)。多因素Cox比例风险回归显示,NLR和2型神经纤维瘤病是再次治疗的独立预测因素(分别为P = 0.0423和0.0043)。在以下亚组中,NLR≥2.21的患者TFS显著缩短:散发性神经鞘瘤、原发性神经鞘瘤、大小≥30 mm的神经鞘瘤、次全切除、前庭神经鞘瘤和术后复发。

结论

术前NLR≥2.21与神经鞘瘤切除术后再次治疗显著相关。NLR可能是再次治疗的一个新的预测指标,并有助于外科医生在术前进行手术决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/187b/9950385/5650abee0f02/fonc-13-1099384-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验